New expert committee to consult on drug pricing, new drug launches

According to DoP's latest order, the committee would deliberate and make recommendations on the claims of pharmaceutical cos about additional therapeutic features associated with any drug formulation and bulk drug.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news